Effects of drag reducing polymer on atherosclerosis

Area of Science:

• Biomedical Engineering
• Cardiovascular Research
• Polymer Science

Background:

• Atherosclerosis is a chronic inflammatory disease characterized by plaque buildup in arteries.
• High cholesterol diets are a primary risk factor for the development of atherosclerosis.
• Drag reducing polymers are known for their ability to decrease turbulence in fluid flow.

Purpose of the Study:

• To investigate the inhibitory effect of a drag reducing polymer (polyacrylamide) on atherosclerosis.
• To evaluate the impact of polyacrylamide on atherosclerosis in guinea pigs consuming a high cholesterol diet.
• To assess the efficacy of drag reducing polymers in preventing arterial plaque formation.

Main Methods:

• Guinea pigs were divided into four groups: control, polymer, cholesterol, and cholesterol + polymer.
• Animals were fed a 2% high cholesterol diet for 6 months.
• Macroscopic and light microscopic examinations of aortas, livers, kidneys, and lungs were performed.
• Physiological parameters including plasma cholesterol, hemoglobin, hematocrit, and total lipids were monitored.

Main Results:

• Significant suppression of atherosclerosis was observed in the aortas of animals receiving polymer injections.
• Polyacrylamide administration mitigated the development of atherosclerotic lesions in the aorta.
• No significant adverse effects were noted in other organs examined.

Conclusions:

• Drag reducing water-soluble polymers, specifically polyacrylamide, demonstrate a significant inhibitory effect on atherosclerosis.
• These polymers hold promise as a potential therapeutic strategy for the prevention and treatment of atherosclerosis.
• Further research is warranted to explore the clinical application of drag reducing polymers in cardiovascular disease management.